AsymBio

AsymBio is a technology-driven Contract Development and Manufacturing Organisation (CDMO) specialising in biologics development and production.

Established in 2019, AsymBio is a core unit of Asymchem Group. The company is committed to delivering efficient, customisable, and high-quality services to clients worldwide. Operating under a flexible and cooperative business model with the motto "customer-first, quality-first," AsymBio empowers the progress of the biopharmaceutical industry through innovative technologies and platform solutions.

Key Products and Services

Process Development: Comprehensive capabilities in developing processes for antibodies, recombinant biotherapeutics, bioconjugates, plasmids, and mRNAs.

Product Manufacturing: Expertise in manufacturing drug substances and drug products, including fill-finish services.

Analytical Development and Testing: Robust analytical services ensuring product quality and compliance with regulatory standards.

Regulatory Affairs: Support for domestic and overseas regulatory registration and submission filings.

AsymBio's commitment to stringent quality standards is evidenced by its successful completion of approximately 20 cGMP audits since 2021. The company's dedication to continuous improvement and client satisfaction positions it as a trusted partner in the global biopharmaceutical industry.